PTC Therapeutics
PTCT
#2737
Rank
A$9.04 B
Marketcap
A$112.62
Share price
-2.70%
Change (1 day)
49.97%
Change (1 year)

PTC Therapeutics (PTCT) - Net assets

Net assets on the balance sheet as of September 2025 : -A$0.24 Billion

According to PTC Therapeutics 's latest financial reports the company has -A$0.24 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

PTC Therapeutics - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-A$1.77 Billion46.94%
2023-12-31$-A$1.21 Billion135.56%
2022-12-31$-A$0.52 Billion-25814.25%
2021-12-31$A$1.98 M-99.68%
2020-12-31$A$0.62 B-26.16%
2019-12-31$A$0.84 B70.51%
2018-12-31$A$0.49 B148.46%
2017-12-31$A$0.20 B20.79%
2016-12-31$A$0.16 B-46.52%
2015-12-31$A$0.31 B-14.93%
2014-12-31$A$0.36 B138.24%
2013-12-31$A$0.15 B-928.77%
2012-12-31$-A$18.48 Million-92.06%
2011-12-31$-A$0.24 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Vertex Pharmaceuticals
VRTX
A$26.06 B-11,219.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$1.98 B-947.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.35 B-250.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
A$2.83 B-1,311.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.94 B-501.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$67.34 B-28,831.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland